Haemonetics (HAE) EBITDA Margin (2009 - 2026)
Haemonetics (HAE) posted EBITDA Margin of 16.93% for Q2 2026, up 354.67% on a QoQ basis from 6.65% in Q1 2026, and up 17.0% year-over-year from 14.47% in Q2 2025.
Powered by 
Analysis
Haemonetics (HAE) EBITDA Margin (2009 - 2026) Analysis & Trends
Haemonetics has reported EBITDA Margin for 18 years, with the latest figure at 16.93% in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 17.0% year-over-year to 16.93% in Q2 2026; TTM through Jun 2026 was 11.86%, a 567.0% decrease from a year earlier, with the FY2026 full-year figure at 11.75%, down 455.0% from the prior year.
- EBITDA Margin was 16.93% for Q2 2026 at Haemonetics, up from 6.65% in the prior quarter.
- The five-year high for EBITDA Margin was 21.58% in Q1 2025, with the low at 6.65% in Q1 2026.
- Average EBITDA Margin over 5 years is 13.42%, with a median of 14.18% recorded in 2022.
- The sharpest annual moves came in 2022 and 2026: EBITDA Margin surged 1665 bps in 2022, then plunged 2823 bps in 2026.
- Over 5 years, EBITDA Margin stood at 14.18% in 2022, then slipped by 4 bps to 13.67% in 2023, then advanced by 24 bps to 16.94% in 2024, then increased by 17 bps to 19.88% in 2025, then dropped by 15 bps to 16.93% in 2026.
- The last three EBITDA Margin figures came in at 16.93% (Q2 2026), 6.65% (Q1 2026), and 19.88% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 19.15% |
| 10 | Haemonetics | 4.58 Bn | 4.36 Bn | 202.80 Mn | 16.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 16.93% |
| Mar 28, 2026 | -6.65% |
| Dec 27, 2025 | 19.88% |
| Sep 27, 2025 | 17.87% |
| Jun 28, 2025 | 16.76% |
| Mar 29, 2025 | 21.58% |
| Dec 28, 2024 | 16.94% |
| Sep 28, 2024 | 14.96% |
| Jun 29, 2024 | 11.83% |
| Mar 30, 2024 | 8.72% |
| Dec 30, 2023 | 13.67% |
| Sep 30, 2023 | 11.10% |
| Jul 1, 2023 | 17.24% |
| Apr 1, 2023 | 11.58% |
| Dec 31, 2022 | 14.18% |
| Oct 1, 2022 | 15.71% |
| Jul 2, 2022 | 11.77% |
| Apr 2, 2022 | 7.24% |
| Jan 1, 2022 | 13.72% |
| Oct 2, 2021 | 10.22% |